Temozolomide or bevacizumab for spinal cord high-grade gliomas
Journal of Neuro-Oncology, 06/12/2012
Kaley TJ et al. – This retrospective review suggests that temozolomide and bevacizumab may be beneficial in spinal cord high–grade gliomas. The compact architecture of the spinal cord makes bevacizumab a particularly appealing agent due to the drug’s effect on peritumoral edema and mass effect.